Timing Is Everything for Merck’s COVID Pill: If a result comes too late, or a test seems out of reach, then the sick person can easily miss that crucial early-infection window—a big loss, considering that molnupiravir has essentially “no effect on patients once they’re in hospitals,”

Timing Is Everything for Merck’s COVID Pill: If a result comes too late, or a test seems out of reach, then the sick person can easily miss that crucial early-infection window—a big loss, considering that molnupiravir has essentially “no effect on patients once they’re in hospitals,”: https://ift.tt/2YoNpyr Read more... https://ift.tt/3aikHBX